PDS Biotechnology Shares Down 18% After Phase 3 Trial Modifications

pds biotechnology 股价在第 3 期试验调整后下跌 18%

WSJ · 11/14 14:07

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.